S100P + SPP1− iCCAphl had less CD3+ T and CD56+ NK cells, but more CCL18+ macrophage infiltration than S100P-SPP1 + iCCApps, indicating its dampened anti-tumor immune response that may contribute to the higher invasive potential. The gene discussed is CCL18; the disease is neoplasm.